Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

Fig. 3

Cell death and apoptosis in ovarian cancer cell lines 7-days after treatment with azacitidine, carboplatin, or combined treatment. Cytotox (cell death; green), Annexin V (apoptosis; red), overlap between Cytotox and Annexin V (yellow) (A) No treatment; (B) 0.5 μM azacitidine (C) 20 μM Carboplatin; (D) 0.5 μM azacitidine and 20 μM carboplatin

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us